Dr. Hofmeister on the Treatment of Patients with Newly Diagnosed Myeloma

Craig Hofmeister, MD
Published: Tuesday, Oct 03, 2017



Craig Hofmeister, MD, associate professor, The Ohio State University Comprehensive Cancer Center, discusses the treatment of patients with newly diagnosed multiple myeloma.

Patients with multiple myeloma who are fit are usually able to treated with any available agent, says Hofmeister.

The most effective treatment is usually a 3-drug therapy of an immunomodulatory drug, a protostome inhibitor, and dexamethasone, Hofmeister adds.
 


Craig Hofmeister, MD, associate professor, The Ohio State University Comprehensive Cancer Center, discusses the treatment of patients with newly diagnosed multiple myeloma.

Patients with multiple myeloma who are fit are usually able to treated with any available agent, says Hofmeister.

The most effective treatment is usually a 3-drug therapy of an immunomodulatory drug, a protostome inhibitor, and dexamethasone, Hofmeister adds.
 



View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Hematology Briefings™: Advancing Care and Improving Outcomes for Patients With Pyruvate Kinase DeficiencyOct 31, 20181.0
Rapid Reviews in Oncology®: Practice-Changing Data in Acute Myeloid Leukemia: A Rapid Update From Atlanta OnlineDec 21, 20182.0
Publication Bottom Border
Border Publication
x